| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-11 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-08 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-08 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.19 | 3e-07 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-07 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.19 | 6e-07 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.17 | 8e-07 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-06 |